The vicious cycle of co-occurring disorders such as depression and negative body image can be overcome. Understanding where negative self-talk begins can be an overwhelming endeavor. Many people have become so accustomed to the emphasis our culture places on appearance that obsessing about it seems normal. Sometimes inherited factors may predispose someone to certain issues, including the way a person is raised and to what degree parents or caregivers encourage a positive self-image. Personal experience trauma can have a significant impact and social environment, are also other factors to consider. However, because there is a complex overlap between emotions and self-perception, body image is not always reflective of how an individual actually appears.
Types of Depression
Major Depression Research Paper - Words
Adolescents with negative body image concerns are more likely to be depressed, anxious, and suicidal than those without intense dissatisfaction over their appearance, even when compared to adolescents with other psychiatric illnesses, according to a new study by researchers at Bradley Hospital, Butler Hospital and Brown Medical School. Classic BDD is a preoccupation with an imagined physical defect in appearance or a vastly exaggerated concern about a minimal defect, like a crooked nose or imperfect complexion. Weight-related BDD, however, is classified as distressing and impairing preoccupations with one's weight and shape -- ie: thinking one's thighs are too fat or one's waist is too big. The study found that one third of inpatient adolescents had problematic body image concerns, and that these patients were more severely ill than other adolescent inpatients in a number of important domains.
The Disturbing Effect Our Beauty Standards Have on Women Across the World
Female dissatisfaction with appearance - poor body-image - begins at a very early age. Human infants begin to recognise themselves in mirrors at about two years old. Female humans begin to dislike what they see only a few years later.
Current treatments for depression remain severely limited. Since the introduction of Prozac nearly 30 years ago, there have been no new categories of antidepressants, only variations of the existing SSRIs and SNRIs targeting serotonin and norepinephrine, only two of hundreds of neurotransmitters. In fact, they become worse with repeated episodes of depression. Those that do respond to existing medications often experience troublesome side effects. However, advanced brain research is stalled because government funding has been reduced, and many of the large drug makers have closed their neuroscience research programs.